Submission Details

Submitter:

Classification:
Definitive
GENCC:100001
Gene:
Disease:
intellectual developmental disorder with cardiac defects and dysmorphic facies
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
06/05/2024
Evidence/Notes:

The TMEM94 gene is located on chromosome 17 at 17q25.1 and encodes transmembrane protein 94 which is involved in transport of magnesium ions into the endoplasmic reticulum . TMEM94 was first reported in relation to autosomal recessive intellectual developmental disorder with cardiac defects and dysmorphic facies (IDDCDF) in 2018 (Stephen et al., PMID: 30526868). IDDCDF is a syndromic neurodevelopmental disorder characterized by globally impaired development with intellectual disability and speech delay, congenital cardiac malformations, and dysmorphic facial features. Individuals with this condition present with various types of structural congenital heart disease, including atrial septal defect, ventricular septal defect, and tetralogy of fallot. Ten unique variants (6 frameshift, 1 nonsense, 3 splice-site) that have been reported in 12 probands with IDDCDF in 7 publications are included in this curation (PMIDs: 30526868, 32825426, 30919572, 31607746, 32552793, 37644014, 34374989). Most probands were born from consanguineous parents and variants were identified in a homozygous state in 10 of the 12 probands. More evidence is available in the literature but the maximum score for genetic evidence (12 pts) has been reached.The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by a mouse modelwhere the homozygous null variants fully replicated the human phenotype (PMID: 30526868). In summary, there is definitive evidence to support the relationship between TMEM94 and autosomal recessive tntellectual developmental disorder with cardiac defects and dysmorphic facies. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Syndromic GCEP on the meeting date June 5th, 2024 (SOP Version 10).

PubMed IDs:
30526868 30919572 31607746 32552793 32825426 34374989
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.